𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction

✍ Scribed by Philip C. Fox; Peter F. van der Ven; Bruce J. Baum; Irwin D. Mandel

Book ID
113197908
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
581 KB
Volume
61
Category
Article
ISSN
0030-4220

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Functional outcomes related to the preve
Functional outcomes related to the prevention of radiation-induced xerostomia: Oral pilocarpine versus submandibular salivary gland transfer
✍ Jana M. Rieger; Naresh Jha; Judith A. Lam Tang; Jeffrey Harris; Hadi Seikaly πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 136 KB

## Abstract ## Background Xerostomia has a devastating impact on oral function and quality of life in patients who receive radiation treatment for head and neck cancer. The purpose of this study was to examine functional outcomes related to 2 saliva‐sparing treatments: (1) oral pilocarpine during

Phase III randomized study: Oral pilocar
Phase III randomized study: Oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia
✍ Naresh Jha; Hadi Seikaly; Jeffrey Harris; David Williams; Khalil Sultanem; Micha πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 190 KB

## Abstract ## Background. Xerostomia is a serious morbidity of radiation treatment in head and neck cancer. ## Methods. We conducted a prospective phase III multicenter randomized study comparing submandibular salivary gland transfer (SGT) procedure with pilocarpine during and for 3 months afte